New shot aims to tame BK virus in kidney transplant patients
Disease control
Not yet recruiting
This study tests whether a new drug, AIC263029, is safe and can lower BK virus levels in adult kidney transplant recipients. Participants will receive weekly injections for 4 weeks and be monitored for about 6 months. The goal is to control the virus, not cure it, as transplant p…
Phase: PHASE2 • Sponsor: AiCuris Anti-infective Cures AG • Aim: Disease control
Last updated May 26, 2026 10:48 UTC